Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA recognition of standards

This article was originally published in The Gray Sheet

Executive Summary

Draft guidance on use of the International Electrotechnical Commission's 60601 safety standards for devices will not be finalized, FDA says in an Oct. 16 Federal Register notice. Instead, the agency formally recognizes the 60601 standards by listing them in the notice, along with 240 other standards posted on FDA's website in August. "There appears to be little, if any benefit to finalizing guidance on FDA's use of IEC 60601 standards in a separate document," the notice says

You may also be interested in...



IEC Electromedical Safety Standard Third Edition Expected In August 2005

Manufacturers planning declarations of conformity to the third edition of the International Engineering Consortium's electromedical equipment standard should come into compliance with international risk management standard ISO 14971, panelists at a recent AAMI/FDA meeting suggested

QUOTED. 3 April 2020. Minetta Liu.

Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.

UsernamePublicRestriction

Register

MT010781

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel